ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Maat Pharma SA

Maat Pharma SA (MAAT)

7.40
0.00
( 0.00% )
Updated: 04:30:55

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
7.40
Bid
7.36
Ask
7.40
Volume
425
7.34 Day's Range 7.40
4.50 52 Week Range 9.90
Market Cap
Previous Close
7.40
Open
7.40
Last Trade
174
@
7.4
Last Trade Time
08:05:16
Financial Volume
-
VWAP
-
Average Volume (3m)
2,102
Shares Outstanding
11,616,199
Dividend Yield
-
PE Ratio
-4.36
Earnings Per Share (EPS)
-1.7
Revenue
2.23M
Net Profit
-19.72M

About Maat Pharma SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Lyon, Rhone, Fra
Founded
1970
Maat Pharma SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker MAAT. The last closing price for Maat Pharma was 7.40 €. Over the last year, Maat Pharma shares have traded in a share price range of 4.50 € to 9.90 €.

Maat Pharma currently has 11,616,199 shares outstanding. The market capitalization of Maat Pharma is 85.96 € million. Maat Pharma has a price to earnings ratio (PE ratio) of -4.36.

MAAT Latest News

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Article 223-16 of the General Regulations of the Financial Markets Authority (AMF - Autorité des Marchés Financiers) Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a...

MaaT Pharma: Half-year Report and an Increase of the Resources Allocated to the Liquidity Contract With Kepler Cheuvreux

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma annonce le résultat positif du premier DSMB pour l'essai clinique de Phase 2 en cours évaluant MaaT033 pour les patients recevant une allo-GCSH

Le DSMB (Data Safety and Monitoring Board), un comité d’experts indépendants, a recommandé que l'essai se poursuive comme prévu et sans modifications. MaaT033 a montré un profil de sécurité...

MaaT Pharma Announces Initiation of Coverage of its Stock by Stifel with a Buy Rating and a Target Price of EUR 16

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé...

MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma announces the successful completion of its Global Offering of 19.2 Million Euros

Regulatory News: THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-0.8042895442367.467.57.34647.4025323DE
40.162.209944751387.248.14716807.70621499DE
12-2.1-22.10526315799.59.586.5221027.8377777DE
260.162.209944751387.249.96.5217908.16968804DE
521.0215.9874608156.389.94.517317.33545966DE
156-6.1-45.185185185213.514.44.513419.50666239DE
260-6.1-45.185185185213.514.44.513419.50666239DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ATPCAgape ATP Corporation
$ 0.389499
(172.38%)
24.66M
WRNTWarrantee Inc
$ 0.7581
(160.52%)
43.43M
GPAKGamer Pakistan Inc
$ 0.3666
(120.71%)
34.16M
NMHINatures Miracle Holding Inc
$ 0.5646
(61.31%)
13.21M
ADILAdial Pharmaceuticals Inc
$ 1.58
(49.06%)
5.92M
JAGXJaguar Health Inc
$ 1.40
(-67.21%)
3M
RNAZTransCode Therapeutics Inc
$ 0.30
(-62.15%)
1.59M
MIRAMIRA Pharmaceuticals Inc
$ 3.66
(-26.95%)
5.81M
BREABrera Holdings PLC
$ 0.5679
(-22.95%)
1.97M
XCURExicure Inc
$ 0.40
(-19.97%)
66.42k
WRNTWarrantee Inc
$ 0.7581
(160.52%)
43.43M
GPAKGamer Pakistan Inc
$ 0.375
(125.77%)
34.19M
ATPCAgape ATP Corporation
$ 0.399
(179.02%)
24.78M
WBUYWeBuy Global Ltd
$ 0.1974
(22.68%)
17.32M
NMHINatures Miracle Holding Inc
$ 0.56
(60.00%)
13.22M

Discussion

View Full Feed
glenn1919 glenn1919 3 minutes ago
LUXH......SOAR............................https://stockcharts.com/h-sc/ui?s=SOAR&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=LUXH&p=W&b=5&g=0&id=p84354014936
LUXH
scho1560 scho1560 3 minutes ago
Yea, I guess I am confused. After reading through the results, it sounds like the subgroups did see market improvements. So, to me it sounds like positive news. However it did not meet all their expectations.

What was everyone else's take away?
JAGX
peanutz peanutz 3 minutes ago
They are very good at responding to email . I'm going to hold mine .
PPCB
WeTheMarket WeTheMarket 3 minutes ago
Repost from FCEL board, courtesy of Hoghead7.

Toyota And A Company Called Fuel Cell Energy Make A Case For Hydrogen
Capturing dangerous methane to make electricity and hydrogen makes the most sense.
BY MARK VAUGHNPUBLISHED: MAY 07, 2024
https://www.autoweek.com/ne
FCEL
TrendTrade2016 TrendTrade2016 4 minutes ago
AZTR BLOWING UP
AZTR
getmoreshares getmoreshares 4 minutes ago
is IHUB slower than normal today-- or- just my connection?? TIA
HIRU
mattymatt66 mattymatt66 4 minutes ago
Would rather have him day to day on the payroll as CRO vs. BoD member, but I’ll take it.
LWLG
dshade dshade 4 minutes ago
The CEO provides leadership for all aspects of the company's operations with an emphasis on long-term goals, growth, profit, and return on investment.
ECSL
WeTheMarket WeTheMarket 4 minutes ago
Reposts from FCEL board, courtesy of Hoghead7.

Toyota And A Company Called Fuel Cell Energy Make A Case For Hydrogen
Capturing dangerous methane to make electricity and hydrogen makes the most sense.
BY MARK VAUGHNPUBLISHED: MAY 07, 2024
https://www.autoweek.com/n
FCEL
4u2nv2 4u2nv2 4 minutes ago
Oops. Glow plugs........
MCIC
LVerstee LVerstee 4 minutes ago
You may want to read up.

https://adviserinfo.sec.gov/firm/brochure/324665
ITUP
facts_matter14 facts_matter14 4 minutes ago
Of course, she attacks you for being honest about things, and it goes against her bullshit.

Ask her the same question she asked you:

Can we hold you responsible for these comments?

https://investorshub.advfn.com/uimage/uploads/2024/7/23/lpkuyIMG_4804.jpeg
SRMX
glenn1919 glenn1919 5 minutes ago
LUXH.......................................https://stockcharts.com/h-sc/ui?s=LUXH&p=W&b=5&g=0&id=p86431144783
LUXH
getmoreshares getmoreshares 5 minutes ago
today, farside was better than normal
ruskie1 ruskie1 5 minutes ago
Patrik, not trying to be negative Nancy , but with Thompson, you cannot predict anything about this man. It’s looking like more and more back to the original game… years ago it was the word commercial commercial commercial used in practically every PR and people thought that it’s about to happen and
KBLB
peanutz peanutz 5 minutes ago
The culture of " right now " has always been around. Patience will pay off . IMHO lol
RONN
Rainer Rainer 5 minutes ago
on watch for a reversal here soon. GLTA
SMCE
$PennyMover $PennyMover 6 minutes ago
GM - Just keeps making new highs. Pre-market is doing it again.
GM
scubastevemd scubastevemd 6 minutes ago
Most likely correct. Not sure if the savings and increased revenue offset the cost of taken such actions, but we will see soon. They did somewhat warn on this, but I am wonder if there's something more to this. I do wonder how much they have kicked back to the DNC and wonder how they hide it.
PLUG
irishintelligence irishintelligence 6 minutes ago
https://x.com/prism_mediawire/status/1815730908407660980?s=46&t=k3ixzdZ_2ivgwM9btgpg1A
SPZI
stink stack stink stack 6 minutes ago
Let it Ride ,........
FNMA
CaptBeer CaptBeer 6 minutes ago
https://x.com/GeoWizz_/status/1815731121348350279
AMRN
Rainer Rainer 7 minutes ago
nice news
BIEI
Louied91 Louied91 7 minutes ago
$SPZI JP 3E Holdings, Inc. Completes Acquisition of Stake in Bloxcross, Inc.

https://www.globenewswire.com/en/news-release/2024/07/23/2917197/0/en/JP-3E-Holdings-Inc-Completes-Acquisition-of-Stake-in-Bloxcross-Inc.html

NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- JP 3E H
SPZI

Your Recent History

Delayed Upgrade Clock